Tumor invasion in the central airway is a risk factor for early‐onset checkpoint inhibitor pneumonitis in patients with non‐small cell lung cancer

BACKGROUND: Anti‐programmed death‐1 (PD‐1) immunotherapy can cause immune‐related pneumonitis, also known as checkpoint inhibitor pneumonitis (CIP). CIP that develops early after the initiation of anti‐PD‐1 immunotherapy is important because it is more severe than CIP that develops later. However, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Moda, Mitsuhiro, Saito, Haruhiro, Kato, Terufumi, Usui, Ryo, Kondo, Tetsuro, Nakahara, Yoshiro, Murakami, Shuji, Yamamoto, Kouji, Yamada, Kouzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705619/
https://www.ncbi.nlm.nih.gov/pubmed/33078531
http://dx.doi.org/10.1111/1759-7714.13703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705619/
https://www.ncbi.nlm.nih.gov/pubmed/33078531
http://dx.doi.org/10.1111/1759-7714.13703

Ejemplares similares